Total Receivables - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Portage Biotech Inc
Total Receivables Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Total Receivables
$86k
CAGR 3-Years
-54%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Total Receivables
$13.6m
CAGR 3-Years
8%
CAGR 5-Years
0%
CAGR 10-Years
13%
Repare Therapeutics Inc
NASDAQ:RPTX
Total Receivables
$15.3m
CAGR 3-Years
35%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Receivables
$25.5m
CAGR 3-Years
80%
CAGR 5-Years
164%
CAGR 10-Years
74%
Covalon Technologies Ltd
XTSX:COV
Total Receivables
CA$6.3m
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
20%
Spectral Medical Inc
TSX:EDT
Total Receivables
CA$352k
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
-6%

See Also

What is Portage Biotech Inc's Total Receivables?
Total Receivables
86k USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Total Receivables amounts to 86k USD.

What is Portage Biotech Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
-26%

Over the last year, the Total Receivables growth was -89%. The average annual Total Receivables growth rates for Portage Biotech Inc have been -54% over the past three years , -26% over the past five years .

Back to Top